Zoladex® (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (6)

• W1742897810 via openalex
• W1981326009 via openalex
• W2035401846 via openalex
• W2038672763 via openalex
• W2054593384 via openalex
• W2154153850 via openalex

Cited by (9)

• Effect of goserelin in quality of life of women with abnormal uterine bleeding and leiomyoma: a case series 2023
• Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo-controlled, double-blind trial 2006
• Treatment of dysfunctional uterine bleeding in the perimenopause: The effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment – a randomized, placebo-controlled, double-blind trial 2006
• Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia 2004
• GnRH analogue in everyday gynecology, Is it possible to rationalize its use? 1999
• Diaphragmatic endometriosis 1999
• 4 Indications and alternatives to hysterectomy 1997
• Goserelin 1996
• Report on a conference on developments in the treatment of benign gynecological disorders 1992

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:11:49.821429+00:00